Comparison of patient characteristics between the discordant and nondiscordant groups
| Characteristic . | Nondiscordant . | Discordant . | Total . | P . | ||
|---|---|---|---|---|---|---|
| n . | % . | n . | % . | |||
| Age | ||||||
| < 60 y | 209 | 26 | 35 | 32 | 244 | .17 |
| ≥ 60 y | 597 | 74 | 74 | 68 | 671 | |
| Sex | ||||||
| Female | 308 | 38 | 40 | 37 | 348 | .76 |
| Male | 498 | 62 | 69 | 63 | 567 | |
| Diagnosis | ||||||
| RA/RARS/RCMD/RCMD-RS | 355 | 44 | 16 | 14 | 371 | < .001* |
| RAEB | 316 | 39 | 43 | 39 | 359 | |
| RAEB-T | 86 | 11 | 46 | 42 | 132 | |
| MDS-U | 32 | 4 | 3 | 3 | 35 | |
| 5q− | 14 | 2 | 0 | 0 | 14 | |
| CMML | 2 | 0.2 | 1 | 1 | 3 | |
| AML | 1 | 0.1 | 0 | 0 | 1 | |
| IPSS | ||||||
| Low | 161 | 20 | 7 | 6 | 168 | < .001* |
| Intermediate-1 | 291 | 36 | 28 | 26 | 319 | |
| Intermediate-2 | 196 | 24 | 28 | 26 | 224 | |
| High | 102 | 13 | 40 | 37 | 142 | |
| Not applicable | 56 | 7 | 6 | 5 | 62 | |
| Cytogenetics | ||||||
| Diploid | 343 | 43 | 44 | 41 | 387 | .87 |
| −5/−7 | 231 | 29 | 35 | 32 | 266 | |
| Other | 162 | 20 | 22 | 20 | 184 | |
| Insufficient metaphases | 70 | 8 | 8 | 7 | 78 | |
| WBC | ||||||
| <10 | 740 | 92 | 98 | 90 | 838 | .47 |
| ≥ 10 | 61 | 7 | 11 | 10 | 72 | |
| Information not available | 5 | 1 | 0 | 0 | 5 | |
| Platelet | ||||||
| < 100 | 488 | 60 | 79 | 72 | 567 | .05* |
| ≥ 100 | 313 | 39 | 30 | 28 | 343 | |
| Information not available | 5 | 1 | 0 | 0 | 5 | |
| Hemoglobin | ||||||
| <10 | 428 | 53 | 76 | 70 | 504 | .004* |
| ≥ 10 | 373 | 46 | 33 | 30 | 406 | |
| Information not available | 5 | 1 | 0 | 0 | 5 | |
| Marrow blasts | ||||||
| 0-4 | 436 | 54 | 18 | 17 | 454 | < .001* |
| 5-10 | 162 | 20 | 32 | 29 | 194 | |
| 11-20 | 115 | 14 | 25 | 23 | 140 | |
| > 20 | 64 | 8 | 33 | 30 | 97 | |
| Not done/not applicable | 29 | 4 | 1 | 1 | 30 | |
| Transformation to AML | ||||||
| Yes | 75 | 9 | 10 | 9 | 85 | .96 |
| No | 731 | 91 | 99 | 91 | 830 | |
| Characteristic . | Nondiscordant . | Discordant . | Total . | P . | ||
|---|---|---|---|---|---|---|
| n . | % . | n . | % . | |||
| Age | ||||||
| < 60 y | 209 | 26 | 35 | 32 | 244 | .17 |
| ≥ 60 y | 597 | 74 | 74 | 68 | 671 | |
| Sex | ||||||
| Female | 308 | 38 | 40 | 37 | 348 | .76 |
| Male | 498 | 62 | 69 | 63 | 567 | |
| Diagnosis | ||||||
| RA/RARS/RCMD/RCMD-RS | 355 | 44 | 16 | 14 | 371 | < .001* |
| RAEB | 316 | 39 | 43 | 39 | 359 | |
| RAEB-T | 86 | 11 | 46 | 42 | 132 | |
| MDS-U | 32 | 4 | 3 | 3 | 35 | |
| 5q− | 14 | 2 | 0 | 0 | 14 | |
| CMML | 2 | 0.2 | 1 | 1 | 3 | |
| AML | 1 | 0.1 | 0 | 0 | 1 | |
| IPSS | ||||||
| Low | 161 | 20 | 7 | 6 | 168 | < .001* |
| Intermediate-1 | 291 | 36 | 28 | 26 | 319 | |
| Intermediate-2 | 196 | 24 | 28 | 26 | 224 | |
| High | 102 | 13 | 40 | 37 | 142 | |
| Not applicable | 56 | 7 | 6 | 5 | 62 | |
| Cytogenetics | ||||||
| Diploid | 343 | 43 | 44 | 41 | 387 | .87 |
| −5/−7 | 231 | 29 | 35 | 32 | 266 | |
| Other | 162 | 20 | 22 | 20 | 184 | |
| Insufficient metaphases | 70 | 8 | 8 | 7 | 78 | |
| WBC | ||||||
| <10 | 740 | 92 | 98 | 90 | 838 | .47 |
| ≥ 10 | 61 | 7 | 11 | 10 | 72 | |
| Information not available | 5 | 1 | 0 | 0 | 5 | |
| Platelet | ||||||
| < 100 | 488 | 60 | 79 | 72 | 567 | .05* |
| ≥ 100 | 313 | 39 | 30 | 28 | 343 | |
| Information not available | 5 | 1 | 0 | 0 | 5 | |
| Hemoglobin | ||||||
| <10 | 428 | 53 | 76 | 70 | 504 | .004* |
| ≥ 10 | 373 | 46 | 33 | 30 | 406 | |
| Information not available | 5 | 1 | 0 | 0 | 5 | |
| Marrow blasts | ||||||
| 0-4 | 436 | 54 | 18 | 17 | 454 | < .001* |
| 5-10 | 162 | 20 | 32 | 29 | 194 | |
| 11-20 | 115 | 14 | 25 | 23 | 140 | |
| > 20 | 64 | 8 | 33 | 30 | 97 | |
| Not done/not applicable | 29 | 4 | 1 | 1 | 30 | |
| Transformation to AML | ||||||
| Yes | 75 | 9 | 10 | 9 | 85 | .96 |
| No | 731 | 91 | 99 | 91 | 830 | |
Statistically significant (P = .05).